Skip to main content
Log in

Cushing’s syndrome with adrenal suppression and masked hyperandrogenism by high-dose medroxyprogesterone acetate for treatment of endometrial cancer in a young woman with polycystic ovarian syndrome

  • Letter to the Editor
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. A.E. Schindler, C. Campagnoli, R. Druckmann, J. Huber, J.R. Pasqualini, K.W. Schweppe, J.H.H. Thijssen, Reprint of classification and pharmacology of progestins. Maturitas 61(1–2), 171–180 (2008). doi:10.1016/j.maturitas.2008.11.013

    Article  PubMed  Google Scholar 

  2. V. Hug, S. Kau, G.N. Hortobagyi, L. Jones, Adrenal failure in patients with breast carcinoma after long-term treatment of cyclic alternating oestrogen progesterone. Br. J. Cancer 63(3), 454–456 (1991)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. L. Anttila, P. Koskinen, H.L. Kaihola, R. Erkkola, K. Irjala, K. Ruutiainen, Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries. Fertil. Steril. 58(4), 697–702 (1992)

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eun Sook Kim.

Ethics declarations

Conflict of interest

The authors have nothing to declare as a conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 24 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seo, Y., Jeong, E.G. & Kim, E.S. Cushing’s syndrome with adrenal suppression and masked hyperandrogenism by high-dose medroxyprogesterone acetate for treatment of endometrial cancer in a young woman with polycystic ovarian syndrome. Endocrine 50, 519–521 (2015). https://doi.org/10.1007/s12020-015-0722-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-015-0722-7

Keywords

Navigation